Amphastar Pharmaceuticals, Inc. (AMPH) vs First Tracks Biotherapeutics Inc (TRAX)

A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and First Tracks Biotherapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Amphastar Pharmaceuticals, Inc. logo
AMPH
Amphastar Pharmaceuticals, Inc.
$1.14B
$25.91HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
First Tracks Biotherapeutics Inc logo
TRAX
First Tracks Biotherapeutics Inc
$1.10B
$31.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AMPH vs TRAX

growth of $100 · dividends reinvested · last 1y
AMPH +24.1% (+24.1%/yr)TRAX +73.6% (+73.6%/yr)TRAX compounded faster over this window
100150200250Start $100$124$174
AMPH TRAX

AMPH vs TRAX: by the numbers

  • •AMPH is the larger company ($1.14B vs $1.10B market cap).
  • •AMPH is profitable (10.76% net margin) while TRAX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAMPHTRAX
P/E ratio15.33N/A
Forward P/E8.72N/A
PEG ratio0.11N/A
P/S ratio1.56N/A
P/B ratio1.496.49
EV / EBITDA8.95N/A
FCF yield13.38%N/A

Profitability

MetricAMPHTRAX
Gross margin47.68%0.00%
Operating margin15.66%0.00%
Net margin10.76%0.00%
ROE10.23%-57.77%
ROIC5.93%-59.76%

Growth (annualized)

MetricAMPHTRAX
Revenue CAGR (5Y)13.71%N/A
EPS CAGR (5Y)134.23%N/A
FCF CAGR (5Y)23.90%N/A
Total return CAGR (5Y)6.13%N/A

Frequently asked

Is AMPH or TRAX more profitable?
AMPH runs the higher net margin — AMPH at 10.76% versus TRAX at 0.00%.

Go deeper

Full AMPH analysisFull TRAX analysisInteractive comparison tool

Dig into the metrics

Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEFirst Tracks Biotherapeutics ROEAmphastar Pharmaceuticals operating marginFirst Tracks Biotherapeutics operating marginAmphastar Pharmaceuticals revenue growthFirst Tracks Biotherapeutics revenue growthAmphastar Pharmaceuticals free cash flowFirst Tracks Biotherapeutics free cash flow

Amphastar Pharmaceuticals & First Tracks Biotherapeutics appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.